Industry: Medical Testing
Matritech Inc. , based in Newton , Mass. , is using its proprietary nuclear matrix protein ( NMP ). technology , discovered at the Massachusetts Institute of Technology and licensed exclusively to Matritech , to develop and commercialize innovative serum- , cell- and urine-based NMP diagnostics that enable physicians to reliably detect and monitor the presence of bladder , colon , cervical , breast and prostate cancers. Matritech’s nuclear matrix protein ( NMP ) technology platform correlates levels of NMPs in body fluids and tissues to the presence of cancer. Multiple published clinical studies have validated this ability of NMPs to detect early-stage cancerous abnormalities. Matritech has a deep pipeline of NMP-based products in pre-clinical and clinical development. ( www.matritech.com )
Matritech , Inc.
330 Nevada St
Newton, Massachusetts 02460
USA
Tel: (617) 928-0820
Fax: (617) 928-0821